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Abstract
Background: Diabetes mellitus (DM) is a common disease found all over the world, including Indonesia. The DM often found in pediatric patients is DM Type 1. The DM patients with uncontrolled blood glucose will likely suffer multiple organ damage, most notably to the kidneys, eyes, heart, and nerves. To help monitor blood glucose levels, lab checkups such as fasting blood glucose, 2 hours postprandial, and Hemoglobin A1C 
(HbA1C) levels are done. The aim of this study was to determine the profile of blood glucose and HbA1C in pediatric patients  with DM Type 1.
Methods: The study was held in August to October 2014, using descriptive method and cross sectional design. Data were obtained from 28 medical records of DM Type 1 patients in the Department of Child Health at Dr. Hasan Sadikin General Hospital. The variables of this study were blood glucose level and HbA1 in three consecutive examinations. The collected data was presented in tables.
Results: The patients were 19 female and 9 male, most of the patients aged between 11–15 years old. Data 
reported that on first, second, and third examination, most subjects had both fasting blood glucose and 2 
hours postprandial blood glucose levels over 180 mg/dl. On first and second HbA1c checkup, most subjects had values over 10%, and on third checkup had results ranging from 8 to 9.9%.
Conclusions: Most patients are girls and aged between 11–15 years old. The most have uncontrolled blood glucoselevel and HbA1c levels. 
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IntroductionDiabetes Mellitus (DM) is a common disease found all over the world. Currently, approximately 2.8% of the world’s population has DM, and study estimated, it will reach 4.4% by 2030,1 including DM Type 1 patients. 
According to the Basic Health Reserach (Riset 
Kesehatan Dasar/Riskesdas), in Indonesia there was an increase of DM patients from 1.1% by 2007 to 2.1% by 2013. The DM that develops in children is DM Type 1. The DM Type 1 is caused by an autoimmune process, resulting in destruction of pancreatic beta cells and thus, the decrease of insulin production. This abnormality in pancreas is usually permanent. DM Type 1 commonly develops in children aged 7–15 years old, although it can occur at all ages.2 Most parents 
are unaware that their children suffers DM Type 1, mainly due to lack of knowledge about DM Type 1.3The typical clinical presentation of DM Type 1 is polyuria, polydipsia, polyphagia and progressive loss of body weight despite adequate if not excessive eating. Mostly, DM Type 1 patients are diagnosed after suffering complications such as diabetic ketoacidosis (DKA).4 DM patients with uncontrolled blood glucose levels will suffer in various organ–kidneys, eyes, heart and neurologic–dysfunctions.5 The hyperglycemic state cause functional alterations and target of organ damage. Fasting blood glucose (FBG), 2 hours post prandial (2hPP) blood glucose, and Hemoglobin A1c (HbA1C) are laboratory parameter to monitor the blood glucose levels. Blood glucose and HbA1c monitoring 
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are essential in preventing complications especially DKA. HbA1C measurement provides the overview of average blood glucose levels within eight to twelve weeks duration.7 
Some advantages of HbA1C test are; that it can be done anytime and it does not need any 
specific preparation such as fasting. HbA1C and blood glucose measurement results are used to diagnose DM. Diagnosis of DM when 
HbA1C levels ≥6.5%. Internal Committee and American Diabetes Association in 2010 recommended that HbA1C measurement, can be used for screening in individuals with high risk for diabetes.8 The aim of this study was to 
determine the profile of blood glucose level and HbA1C in DM type 1 pediatric patients.  
MethodsThis descriptive study was carried out using medical records of DM Type 1 patients in Dr. Hasan Sadikin General Hospital. All subjects 
that fulfilled the inclusion criteria, that was having the HbA1c measurements in three consecutive from August to October 2014. This study had been approved by the Health 
Research Ethics Committee Dr. Hasan Sadikin General Hospital Bandung.From 42 subjects, 14 subjects did not meet the inclusion criteria, and the other 28 subjects 
that fulfilled the inclusion criteria were studied further. Data that was used as variables were characteristics (age, gender), fasting blood glucose measurement, 2 hours post prandial blood glucose (2hPPBG) measurement, and HbA1c measurement. The collected data were presented in tables.
From 20 subjects, in the first measurement, 13 subjects had blood glucose levels over 180 mg/dl. In the second measurement, majority of the subjects were still inside the over 180 mg/dl category, even though there were 3 subjects decrease. Note that in the second measurement, 1 subject had no result. In the third measurement, 9 subjects were in the over 180 mg/dl category, which showed 1 subject decrease compared to the second measurement. However, the number of subjects were the same (9 subjects) in the less than 180 mg/dl category, and there were two subjects without results.
From 28 subjects, in the first measurement, the majority of subjects had HbA1c levels above 10%, which categorized them in poor metabolic control. In the second measurement, most subjects were still in the poor metabolic control category, with 1 subject decrease. In the third measurement, there was a large decrease 
Table 1 Subject Characteristics 
Patient Profile nGender  Male 9Female 19Age  < 5 years old 3
6–10 years old 711–15 years old 14> 15 years old 4
in the poor metabolic control category, as 
much as 6 subjects, making most subjects in this measurement, as much as 13 subjects, categorized in moderate metabolic control.
ResultsThis study discovered that from 28 patients, most of them were female and between 11 to 15 years old (Table 1).
From 20 subjects, in the first measurement, most subjects (14 subjects), had fasting blood glucose levels over 180 mg/dl. In the second measurement, most subjects still had fasting blood glucose levels over 180 mg/dl, but it were 3 subjects less. In the third measurement, majority of the subjects still had FBG levels over 180 mg/dl, and there were 2 subjects increase compared to the second measurement.
From 20 subjects, in the first measurement, 13 subjects had blood glucose levels over 180 mg/dl. In the second measurement, majority of the subjects were still inside the over 180 mg/dl category, even though there were 3 subjects decrease. Note that in the second measurement, 1 subject had no result. In the third measurement, 9 subjects were in the over 180 mg/dl category, which showed 1 subject decrease compared to the second measurement. However, the number of subjects were the same (9 subjects) in the less than 180 mg/dl category, and there were two subjects without results.
From 28 subjects, in the first measurement, the majority of subjects had HbA1c levels above 10%, which categorized them in poor metabolic control. In the second measurement, most subjects were still in the poor metabolic control category, with 1 subject decrease. In the third measurement, there was a large decrease in the poor metabolic control category, as 
219
Althea Medical Journal. 2017;4(2)
Anisha Sefina Priatna, R.M.Ryadi Fadil, Nugroho Harry Susanto: Blood Glucose Level and HbA1C in Pediatric Patients with Diabetes Mellitus Type 1
much as 6 subjects, making most subjects in this measurement, as much as 13 subjects, categorized in moderate metabolic control.
DiscussionsIn this study, most DM Type 1 subjects were girls, and most DM Type 1 subjects were aged between 11–15 years old. This was concordant to the general subjects characteristics in the study conducted by Maahs et al.9 This results 
were also well-suited to the theory mentioning the onset of DM Type 1 increase in puberty and more common in girls. This was due to the involvement of estrogen, or genes regulated by 
estrogen, such as interleukin-6. The increasing number of cases in puberty were parallel to the 
increasing number of exposure to infectious agents in the beginning of school days, and also the increasing hormonal activity in puberty, which worked antagonist to insulin.2For the fasting and 2 hours post prandial blood glucose levels, which could be seen in Table 2 and Table 3, there were decreasing 
trend in the first, second, and third measurements. This meant that subjects had satisfactory control  of their blood glucose levels. The HbA1c measurement, which could be seen in table 4, showed that there were 
also a decreasing trend in the first, second, and third measurements. A maintained HbA1c levels showed the subjects’ had  a satisfactory metabolic control of their disease, and therefore will hopefully also decrease, delay, or 
Table 2 Fasting Blood Glucose Levels 
Fasting Blood Glucose
1st measurement 2nd measurement 3rd measurementn n n
<126 mg/dl 5 6 6
126–140 mg/dl 0 0 0140–180 mg/dl 1 2 1>180 mg/dl 14 11 13Total 20 20 20
Table 3 Two Hours Post Prandial Blood Glucose Levels 
2hPPBG*
1st measurement 2nd measurement 3rd measurementn n n<180 mg/dl 7 9 9>=180 mg/dl 13 10 9No results 0 1 2Total 20 20 20
Note: *2 Hours Post Prandial Blood Glucose Levels
Table 4 HbA1c Levels 
HbA1c*
1st measurement 2nd measurement 3rd measurementn n n
<6 % 2 2 1
6–7.9% 7 6 78–9.9% 5 7 13>=10% 14 13 7Total 28 28 28
Note: *Hemoglobin A1c
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even avoid microvascular complications such as retinopathy and nephropathy.2 A continuous 
blood glucose monitoring could benefit in controlling blood glucose and HbA1c levels in DM type 1 patients.10 This monitoring, most importantly and fundamentally, is needed to be done by the subjects and their families. The components that need to be monitored are insulin dose, subjects’ physical activity, and subjects’ diet.2 If there were any discrepancies between the subject’s blood glucose and HbA1c levels, the cause should be searched and determined. Some causes include patients’ compliance in insulin injection, the manner of insulin injection itself, and subjects’ diet program.There were limitations that might interfere with the results of this study. Firstly, the study was done in a very short period of time, making the number of subjects retrieved very limited and maybe not ideal. Secondly, errors due to incomplete data and mistakes in data 
writing made it more difficult analyzing and processing the data.Conclusions of this study are most subjects were girls and aged between 11–15 years old. Most subjects with uncontrolled blood glucose and HbA1c levels decreased in every following measurement. However, most subjects were still in the above normal category. This showed that blood glucose and HbA1c control in most subjects were slowly getting satisfactory.
Recommendations of this study are more proper, organized, complete and maybe computerized data writing could ease the data collecting, and also further study needed to be 
done to determine the factors influencing the blood glucose and HbA1c levels in DM Type 1 patients. In addition, subjects are expected to routinely control and monitor their blood glucose and HbA1c levels, and giving education to the subjects and their families about their disease how to control their blood glucose 
might be beneficial.
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